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Summary 
Cyclodextrins (CDs) are widely used in pharmaceutical analysis due to its 
biodegradability and eco-friendly character. The particular structure of CDs, characterized by 
hydrophobic cavity, enables the formation of inclusion complexes with variety of organic 
compounds. As structures lacking chromophores, CDs could not be detected by Photodiode 
Array (PDA) detector and Corona Charged Aerosol Detector (CAD) was introduced as the most 
appropriate detector for the formed complexes. The aim of the study was to investigate the 
degree of complexation between telmisartan, used as a model substance, and β-CD. Moreover, 
the effect of different β-CD concentrations (5-15 mM) and pH of the aqueous part of mobile 
phase (3-7) on the degree of complexation was also assessed. The intensity of the formed 
complex appeared to be the highest when 15 mM β-CD was used for the complexation. Also, it 
was noticed that the increase in peak areas with an increasing β-CD concentration was more 
evident at pH 7 in comparison with the same trend at lower pH values. The reproducibility of 
the measurement was confirmed by low relative standard deviation (RSD) of peak areas within 
five measurements. These findings support the use of HPLC-CAD methods for studying the 
process of inclusion complexes formation.  
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Liquid chromatography is one of the most frequently used techniques in drug 
analysis, during research and development, as well as in routine control of 
pharmaceutical substances and pharmaceutical products (1). To achieve the desired 
chromatographic efficiency, it is favorable to use organic solvents, in the first place 
acetonitrile. Most organic solvents used in HPLC are toxic and could harmfully impact 
the environment and human health as well (2-4). To avoid the negative consequences of 
large amounts of acetonitrile used during the analysis, different “greening” strategies 
were applied (4). Nowadays, development of green liquid chromatography methods is a 
recognized trend in pharmaceutical analysis (5, 6). In that respect, CDs are applied as 
mobile phase additives allowing an increase of water and simultaneous decrease of 
organic solvent content, resulting in the consequent reduction of analyte’s retention 
times (7, 8). CDs are well-known cyclic oligomers derived from starch. Their particular 
structure, characterized by a hydrophilic outer surface and an internal relatively 
hydrophobic cavity, is responsible for the good water solubility, as well as ability to 
fully or partially encapsulate hydrophobic molecules of suitable size within their cavity 
(9-11).  
In this study, telmisartan (Figure 1), as a representative of the group of sartans, 
was selected as a model substance. Physicochemical characteristics of telmisartan made 
it a suitable candidate to be incorporated in CD cavity. Telmisartan is amphoteric 
compound, weakly dissolved in water, but moderately to highly dissolved in methanol 
or acetonitrile (12).  
 
 





The ability to form inclusion complexes with structurally diverse drugs served as 
a base from which numerous applications of CDs were made in the pharmaceutical 
industry (6, 13). CDs are used to modify the unpleasant smell or taste of the 
pharmaceuticals, their physicochemical instability, low solubility in water and poor 
bioavailability. For this reason CDs are profoundly useful in pharmaceutical industry 
and are incorporated in a number of pharmacopeia sources (14). Moreover, regarding 
the prominent solubilizing potency, as well as, unfavorable permeability through 
hydrophobic bio-membranes, CDs are used very successfully in formulations intended 
for oral, ocular, nasal and, even, parenteral route of drug application (15). Having in 
mind the great attention CDs have attracted, it would be of high importance to 
characterize the formed complexes in more detail, and define the parameters which 
significantly influence the complexation procedure.  
Regarding the detection of the complex, there are certain limitations originating 
from the lack of chromophores in the structure of CDs. Several methods for evaluation 
of inclusion complexes can be found in literature, applying mass spectrometry (MS) or 
nuclear magnetic resonance (NMR) (11, 16, 17). However, these techniques are rather 
expensive, so would not be the first choice for routine analysis. Therefore, a strong need 
for detector generating sensitive and universal response, independent of spectral or 
physicochemical qualities of the investigated compounds, arises. Having in mind the 
aforementioned, the purpose of the study was to investigate the potential of CAD in 
determining the degree of complexation. CAD, as a detector based on aerosol charging, 
generates a universal response over a broad dynamic range regardless of the analyte’s 
structure. Among all so far constructed aerosol based detectors, it stands out as an easy-
to-use and highly sensitive mass dependent detector (18, 19). Thus, suitability of CAD 
to investigate the complexation process occurring between telmisartan and β-CD was 
tested for the first time. We assessed the influence of certain parameters such as β-CD 
concentration and pH of the sample on the intensity of the complex. 
1.1 Theory 
During the past years, scientists have dealt with finding the appropriate technique 
to characterize the complexes formed between CDs and various organic hydrophobic 
compounds (17) . ESI-MS was recognized as soft ionization technique able to study the 
stoichiometry of the formed complexes (16), however the information about the degree 
of complexation was not provided. NMR was also successfully used for stoichiometry 
determination, as well as assessing the complex stability (20, 21), but the same 
limitation as in case of ESI-MS occurred. Furthermore, CAD, as a universal detector 
producing a response independent on the analyte’s structure, was the detector of choice 
(22, 23). CAD’s principle of functioning is reflected in nebulization of analytes together 




droplets are dried to remove the mobile phase. Further, generated aerosol is reaching the 
reaction chamber where it is collided with a stream of positively ionized nitrogen that 
has primarily passed over high voltage corona wire. The positive charge is then 
transferred to the opposing stream of analyte particles and the transferred charge is 
generating a response directly proportional to the amount of the analyte investigated 
(23). The intensity of the signal is dependent on the amount of charge the analyte 
surface can receive, so the detector’s response would mostly depend on the mass of 
investigated analyte (22). Implied phenomenon encompass that larger particles carry 
more charge than smaller ones. As a particle detector, it is believed that CAD produces 
the equal amount of particles if the same amount of different materials is entering 
detector under the stable conditions. However, there is variability in CAD response 
which originates from the influence of different factors affecting the process of particle 
formation. Taking into account the evaporation process, mobile phase components have 
to meet the certain volatility criteria, similar to MS mobile phase requirements (24). In 
the same course, higher content of organic solvent in the mobile phase is beneficial. 
Additionally, mobile phase with higher percentage of organic modifier regulates 
production of larger number of substance particles via lower viscosity. Furthermore, the 
decreased mobile phase flow rate also contributes to enhanced detector response, as in 
the case of HPLC-MS. Apart from being a detector of choice for analytes lacking 
chromophores, CAD’s additional advantage is its ease of use reflected in small number 
of parameters to be optimized (22, 23). 
2. Experimental  
2.1 Chemicals and reagents 
Reference standard substance of telmisartan (2-[4-[[4-methyl-6-(1-
methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid) was 
purchased from Sigma Aldrich Chemie GmbH (Taufkirchen, Germany). β-CD was 
obtained from Acros organics (Geel, Belgium). For mobile phase preparation, deionized 
water obtained from a Simplicity 185 purification system, Millipore (Billerica, MA, 
USA), was used. HPLC-grade acetonitrile was also purchased from Sigma Aldrich, 
while ammonium hydroxide and acetic acid used for pH adjustment were obtained from 
Centrohem d.o.o. (Stara Pazova, Serbia) and Merck (Darmstad, Germany), respectively. 
pH of the aqueous phase and working samples was adjusted on PHM210 Standard pH-
meter (Radiometer Analytical SAS, Lyon, France) equipped with glass electrode. 
Before use, mobile phase and working samples were filtered through 0.45 μm nylon 




2.2 Sample preparation 
Stock solution of telmisartan was prepared by dissolving the appropriate amount 
of the reference standard substance in the mixture of water and acetonitrile (50:50, v/v) 
to obtain the concentration of 0.5 mg mL-1. β-CD stock solutions were prepared by 
dissolving an appropriate amount of β-CD in deionized water to obtain the following 
concentrations: 5 mmol L-1, 10 mmol L-1 and 15 mmol L-1. pH of the working 
solutions was adjusted by addition of ammonium hydroxide or acetic acid. pH was set 
to 3, 5 or 7 and five working solutions were prepared at each pH level. The first 
working solution was consisted of 100 µL of stock solution of telmisartan, 760 µL of 
deionized water with adjusted pH and 140 µL of acetonitrile. The second working 
solution consisted of 760 µL of the stock solution of β-CD in 10 mM concentration, 50 
µL of deionized water with pH set to a certain level and 190 µL of acetonitrile. The 
remaining three working samples contained mixture of stock solution of telmisartan 
(100 µL), stock solution of β-CD in 5 mM, 10 mM and 15 mM concentration, 
respectively (760 µL) and acetonitrile (140 µL). The complexation was assisted by 
vortexing the samples for 1 h before the analyses. 
2.3 Instrumentation 
Experiments were carried out on Dionex Ultimate 3000 HPLC system, equipped 
with Diode Array Detector (DAD) and Corona Veo Charged Aerosol Detector (Thermo 
Fisher Scientific, Germering, Germany), serially connected. Separation was achieved on 
HypersilGOLD-C4 (150 x 4.6mm, 5μm) column (Thermo Fisher Scientific, Germering, 
Germany). The temperature of the column was set to 25 ˚C. Gradient elution with 
mobile phase consisted of mixture of water and acetonitrile was applied according to the 
program presented in Table I. pH of the aqueous part of the mobile phase was set to 3, 5 
or 7 with addition of acetic acid or ammonium hydroxide. Detection on DAD was 
performed at 295 nm, while CAD signal intensity was examined by adjusting the 
parameters presented in Table II. Injection volume was 10 µL.  
 
Table I  Gradient elution program 
 
Time (min) Mobile phase flow (mL min-1) 
Content of acetonitrile 
(%) 
Content of aqueous 
phase (%) 
0 0.7 10 90 
14.0 0.7 90 10 
14.1 0.7 10 90 





Table II  Parameters of CAD 
 
Parameter Optimized values 
Evaporation temperature 50 ˚C 
Filter constant 5 s 
Gain range 10 pA 
Power function 1 
Data rate 10 Hz 
 
The stoichiometry of the formed complexes was confirmed by injecting the 
samples into a mass spectrometer with electrospray ionization (ESI-MS). Experiments 
were performed on TSQ Quantum Access Max (Thermo Fisher Scientific Inc.).  
2.4 Docking study 
Molecular docking studies were performed applying an on-line available software 
Autodock v4.2. (The Scripps Research Institute, CA, U.S.A.) (25). β-CD was labeled as 
host compound and its x-ray crystal structure necessary for the study was retrieved from 
the Brookhaven protein data bank. Calculation of pKa and selection of dominant forms 
of telmisartan at different pH values were performed using Marvin Sketch 4.1.13 
ChemAxon Ltd (Budapest, Hungary) (26). Conformations of telmisartan with minimal 
energy content across the examined pH range were obtained by the MOPAC/AM1 
method of Chem 3D Ultra 7.0.0 (Surrey, UK) (27). They were further used as ligands to 
β-CD for docking study. Auto Dock Tools (ADT) was used for preparation, running and 
analyzing the docking simulation. The Lamarckian Genetic Algorithm (LGA) was 
chosen to search for the best conformers (28). During the docking process, a maximum 
of 100 conformers was considered for each compound. A grid of 40 points in each 
direction (x, y, and z) with grid spacing of 0.375 Å was built centered on the center of 
ligand molecule. The maximum number of energy evaluation was set to 2 500 000. 
 3. Results and discussion  
The stability of the complex formed between CDs and various organic 
hydrophobic compounds mostly depends on size complementarity between drug 
molecule and CD cavity. For that reason, β-CD was chosen as the appropriate one, since 
there is evidence that large cavity of β-CD is a better host for a phenyl group (29, 30). 
This group is also present in telmisartan, which theoretically gives the advantage to β-
CD in comparison with α-CD possessing smaller cavity. Formed inclusion complex is 
additionally stabilized by numerous hydrogen bonds and dipole-dipole interactions 




hydroxyl groups present inside and outside the β-CD cavity (31), which was confirmed 
with docking study explained in more detail in section 3.1.  
To get insight into the whole complexation procedure and to determine the degree 
of complexation and influential parameters, it is necessary to determine the 
stoichiometry between drug and β-CD, and propose the most probable type of binding. 
Complex stoichiometry was proven to be 1:1. Molecular ions of 515.6 m/z, 1135.9 m/z 
and 1650.6 m/z corresponding to telmisartan, β-CD and telmisartan – β-CD complex, 
respectively, were detected in ESI + mode. To preclude the possibility of complexes 
formed in 1:2 or 2:1 ratio, broader m/z range was investigated. Across the range from 
100 – 3000 m/z, no 2785.6 m/z or 2165.2 m/z corresponding to 1:2 or 2:1 complexes, 
could be detected. Moreover, employed ESI-MS confirmed that free drug and formed 
complex are eluting at the same retention times. Knowing the stoichiometry, docking 
study was performed to predict the complex structures.  
3.1 In – silico prediction 
Docking study was performed to predict the type of binding occurring between 
telmisartan and β-CD at different pH values. The results of the performed study gave an 
impression of the orientation of the ligand molecule towards the cavity of β-CD. When 
pH of the sample and aqueous mobile phase is set to 3, telmisartan is predominantly 
present in its dicationic form (81.15 %) with both amino groups protonated. 
Benzimidazole part of the structure of telmisartan is incorporated in β-CD cavity 
(Figure 2a). Benzoic acid part in its non-ionized form remains free for interactions with 
silanol groups of stationary phase. On the other hand, in less acidic conditions (pH 5), 
number of protonated amino groups is equal to the number of deprotonated carboxyl 
groups for 56.59 % of the molecule, so electroneutral state contributes to the overall 
lipophilicity of telmisartan and enables the insertion of benzimidazole part of the 
structure into the cavity of CD, leading to inclusion complex formation (Figure 2b). On 
the other hand, for 30.01 % of the molecule both amino groups of benzimidazole part of 
the structure are protonated at pH 5. Deprotonated carboxyl groups are available for 
interactions with stationary phase. Finally, at pH 7 the structure with only carboxyl 
group deprotonated is dominant (88.10 %). However, the pathway of the complex 
formation remained the same as in previous two cases. Benzimidazole part of the 
structure of telmisartan is entering β-CD cavity (Figure 2c). These findings indicate that 
the type of binding is the same at all examined pHs, leading to the conclusion that 
ionization of carboxylic group and amino groups of benzimidazole makes the 
difference. At pH 3, interactions between free benzoic acid and stationary phase 
outreach the interactions leading to complex formation, unlike the other investigated 






Figure 2: Docking structures 
  2a Telmisartan - β-CD complex formed at pH 3 
  2b Telmisartan - β-CD complex formed at pH 5 
  2c Telmisartan - β-CD complex formed at pH 7 
 
3.2 Investigation of the influence of β-CD concentration and pH on the  
     complexation 
CAD was also employed to determine the degree of complexation and investigate 
its dependence on pH and β-CD concentration. The concentration of telmisartan was 
kept constant in all samples, while β-CD concentration was varied from 5-15 mM, as 
well as pH of the samples and aqueous part of the mobile phase. The influence of pH 
and β-CD concentration on the degree of complexation was investigated by analyzing 
the samples containing telmisartan only, β-CD only and their mixture. As previously 
mentioned, DAD was not the best choice for detection of complexes due to its inability 
to detect compounds without chromophores in their structure. The reason for employing 
DAD was to determine the retention time of free telmisartan. Furthermore, its role was 
to confirm that concentration of telmisartan was equal in all of the investigated samples 
(Figure 3). 
 
Figure 3: Peak areas originating from free and complexed telmisartan with  




On the other hand, CAD was capable to detect free β-CD as well as the complex 
formed between telmisartan and β-CD. When analyzing the mixture of telmisartan and 
β-CD with HPLC-DAD the obtained chromatogram contained only one peak. LC – ESI 
– MS showed that retention time of the observed peak was the same as retention time of 
free telmisartan leading to a conclusion that free telmisartan and formed inclusion 
complex are eluting at the same retention time. On the other hand, when analyzing the 
same mixture with HPLC-CAD, two peaks could be observed (Figure 4).  
 
 
Figure 4:  Chromatogram of β-CD and complex between telmisartan and β-CD obtained  
  from HPLC-CAD 
  
The retention time (tr) of the first peaks is equal to retention time of free β-CD (tr 
= 2.90 min) previously analyzed, confirming that the first peak originates from free 
uncomplexed β-CD. Retention time of the second peak present was the same as 
retention time of free telmisartan (tr = 9.61 min). Consequently, the second peak 
represents telmisartan - β-CD complex. The influence of varying β-CD concentrations 
on complexation was investigated under constant concentration of telmisartan in the 
mixture. In the same manner the influence of different pH on the complexation 








Table III  Signal intensities of the analyzed samples from DAD and CAD at pH = 3,  
 pH = 5 and pH = 7 
 
 pH = 3 pH = 5 pH = 7  
Sample DAD CAD DAD CAD DAD CAD β-CD T + β-CD β-CD T + β-CD β-CD T + β-CD 
T A = 21.6703  tr = 9.48 - 
A = 1.0945  
tr = 9.55 
A = 16.8259  
tr = 10.48 - 
A = 1.1129 
tr = 10.54 
A = 18.9936  
tr = 11.38 - 
A = 0.4787  
tr = 11.46 
β-CD           
(10 mM) - 
A = 45.4792  
tr = 2.77 - 
- A = 32.3598  
tr = 2.79 - - 
A = 30.4554  
tr = 2.78 - 
T + β-CD 
(5 mM) 
A = 21.6744  
tr = 9.47 - 
A = 1.1362  
tr = 9.54 
A = 21.7340  
tr = 10.59 - 
A = 1.4154 
tr = 10.65 
A = 19.5229  
tr = 11.30 - 
A = 0.9638  
tr = 11.37 
T + β-CD 
(10 mM) 
A = 21.6059  
tr = 9.47 
A = 42.0940  
tr = 2.78 
A = 1.1737  
tr = 9.53 
A = 22.1996  
tr = 10.61 
A = 30.1101  
tr = 2.79 
A = 1.5213 
tr = 10.68 
A = 19.2248  
tr = 11.06 
A = 28.9039  
tr = 2.78 
A = 1.2102  
tr = 11.13 
T + β-CD 
(15 mM) 
A = 21.5967  
tr = 9.47 - 
A = 1.2197  
tr = 9.53 
A = 22.7271  
tr = 10.63 - 
A = 1.5286 
tr = 10.70 
A = 19.8777   
tr = 10.80 - 
A = 1.4993 
tr = 10.89 
T – Telmisartan; A – Peak area (mAUX for DAD, pA for CAD); tr – retention 
time 
 
When analyzing free β-CD and β-CD in mixture with telmisartan, in the same 
concentration, the difference in the peak area of β-CD was evident (Figure 5).  
 
 
Figure 5: Difference in peak area of β-CD in the same concentration when analyzed free  
                and in mixture with telmisartan obtained in HPLC-CAD  
 
Moreover, peak areas of telmisartan–β-CD complex were increased with 
increasing β-CD concentrations from 5-15 mM. The difference in peak area of free β-
CD when it was analyzed separately and in mixture with telmisartan also confirmed the 
hypothesis that the degree of complexation is higher with increasing concentrations of 
β-CD (Figure 6). The simultaneous detection on DAD showed that the signal of 




on CAD increases only due to the degree of complexation. Furthermore, the degree of 
complexation was growing with an increasing concentration of β-CD in the sample 
across the investigated pH range (Figure 6 and 7).  
 
 
Figure 6: Comparison of degree of complexation with increasing β-CD concentrations at  
  pH 3 and pH 5 
 
 
Figure 7: Comparison of degree of complexation with increasing β-CD concentrations at  
  pH 3, pH 5 and pH 7 
 
3.3 Reproducibility of the measurement 
The reliability of the presented results was examined through the reproducibility 
test. Low variances between replicates confirmed reproducibility of the complexation. 
Furthermore, significantly lower variances between replicates compared to the variances 




possibility that the variances between samples with different concentration of 
complexation agent originate from the imprecision of the sample preparation 
(complexation) or instrument. To assess the reproducibility of the measurement, five 
identical samples were prepared and analyzed respectively. Five samples containing 
mixture of telmisartan with 5 mM β-CD, five samples containing telmisartan in the 
same concentration with 10 mM β-CD and five samples containing the same 
concentration of telmisartan with 15 mM β-CD were prepared and analyzed. As a 
measure of reproducibility, relative standard deviation (RSD) was calculated, for both 
HPLC-PDA and HPLC-CAD analysis. All of the obtained RSD values were less than 
5% indicating good reproducibility. Results are presented in Table IV.  
 
Table IV  Assay of reproducibility of the measurement 
 
Measurement 
number T + 5 mM β-CD T + 10 mM β-CD T + 15 mM β-CD 
 DAD CAD DAD CAD DAD CAD 
1 20.2146 1.4491 21.6330 1.4764 16.9340 1.1187 
2 20.0409 1.4381 21.7395 1.5373 16.4978 1.1876 
3 19.9300 1.4224 21.6763 1.4921 16.2257 1.1111 
4 19.7824 1.4567 21.5925 1.5602 15.8532 1.1474 
5 19.7072 1.4410 21.5302 1.6443 15.6645 1.0357 
RSD (%) 1.02 0.89 0.37 4.37 3.12 4.99 
 
4. Conclusion 
This study highlighted the potential ofto use HPLC-CAD in complexation 
procedure elucidation. The repeated measurements confirmed that CAD response is 
reproducible. Therefore, the reliability of the obtained results was also proven. An 
increase in β-CD concentration affected the intensity of the complex in a positive 
manner. Effect of pH on the complexation was also shown. At pH 7 the difference in 
peak areas of the complex with increasing β-CD concentrations was larger in 
comparison with the observed differences at pH 3 or 5. Finally, HPLC-CAD could be 
selected as one of the methods for studying complexes with β-CD. Moreover, due to its 
performances and simplicity, it could accompany the other techniques in analytical 
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